We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Pathology

Image: The Deep Visual Spatial Transcriptomics and Proteomics (DVSTP) strategy integrates high-resolution pathology images with spatial transcriptomics and spatial proteomics to reveal the complex intra-tumor heterogeneity. DVSTP predicts molecular profiles from routine pathology slides, making spatial multi-omics more accessible. Whole–tumor 3D reconstruction reveals that SRSF6 drives immune exclusion and poor clinical outcomes (Photo courtesy of Science Bulletin)

3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer

An AI–enabled, 3D spatial multi-omics strategy delineates colorectal tumor architecture and immune infiltration. More...
06 Jun 2026
Image: RMA reporter (magenta) expressed in response to neuronal activity marker (cyan) in the hippocampus (Image courtesy of Sho Watanabe/Rice University)

Blood-Based Method Tracks Gene Activity in the Living Brain

A novel blood-based method enables gene transcription measurement in the living brain for the first time. More...
04 Jun 2026
Image: The approval expands PD-L1 testing on Dako Omnis beyond the assay’s previously cleared indications in non-small cell lung cancer and head and neck squamous cell carcinoma (Photo courtesy of Agilent)

FDA Approval Expands Automated PD-L1 Testing Across Solid Tumors

Agilent’s PD-L1 IHC 22C3 pharmDx has received FDA approval on Dako Omnis to support patient treatment decisions with pembrolizumab. More...
03 Jun 2026
Image: Spatial organization of TLSs within the tumor microenvironment. Image shows TLSs containing T cells (green), B cells (pink), and follicular dendritic cells (cyan), surrounded by tumor cells (red) and stromal cells (yellow) (Photo courtesy of The University of Texas MD Anderson Cancer Center)

AI-Powered Atlas Maps Immune Structures Linked to Cancer Outcomes

An AI approach builds a pan-cancer TLS atlas and delivers a score that improves prognostic and treatment-response stratification. More...
29 May 2026
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

An AI approach that analyzes bone marrow slides could help guide treatment and transplant decisions in myeloma. More...
26 May 2026
Image: Fujifilm’s Synapse Pathology is a comprehensive pathology PACS that streamlines case management through proprietary advances in image digitization (photo courtesy of Fujifilm)

Fujifilm Integrates Structured Reporting into Digital Pathology Workflow

An integrated pathology-to-imaging workflow delivers unified, structured reports to speed tumor boards and support registries. More...
24 May 2026
Image: Graphical Abstract (Eldad D. Shulman et al., AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathology, Cell (2026). DOI: 10.1016/j.cell.2026.04.023)

Rapid AI Tool Predicts Cancer Spatial Gene Expression from Pathology Images

An AI approach predicts tumor spatial gene expression from biopsy images, enabling fast, low-cost mapping for biomarker studies. More...
18 May 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
Prefilled Tubes
Prefilled 5.0ml Tubes


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2026 Globetech Media. All rights reserved.